Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss.
Lewis JW. et al, (2024), Cell rep med, 5
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Kurata K. et al, (2023), Blood cancer j, 13
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Kurata K. et al, (2023), Blood cancer j, 13
Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers.
Agarwal G. et al, (2022), Cancers (basel), 15
Prospective assessment of myeloma tumour burden and bone disease using DW-MRI and exploratory bone biomarkers
Agarwal G. et al, (2022), Hemasphere, 6, 777 - 778
Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival.
Whitburn J. et al, (2022), Sci adv, 8
Development of a mass cytometry-based toolkit to investigate myeloma therapeutic responses ex vivo
Gooding S. et al, (2022), Clinical lymphoma myeloma & leukemia, 22, S71 - S71
Prospective assessment of myeloma tumour burden and bone disease using DW-MRI and exploratory bone biomarkers
Agarwal G. et al, (2022), Clinical lymphoma myeloma & leukemia, 22, S59 - S59